Management of pediatric psoriasis with acitretin: A review

Dermatol Ther. 2018 Jan;31(1). doi: 10.1111/dth.12571. Epub 2017 Nov 1.

Abstract

Psoriasis is a chronic inflammatory disease of the skin which can occur at any age-group. Psoriasis in childhood is not uncommon and has genetic susceptibility but usually, an environmental trigger such as infection is thought to initiate the disease process. Pediatric psoriasis has profound effects on both physical and psychosocial health of the patient. Treatment of mild psoriasis can be done with topical therapies but those which do not respond to topical therapies can be treated with phototherapy and systemic therapies. The use of systemic therapies in childhood is mainly based on the published data, case series, expert opinion and the experience as there is the lack of controlled trials in the age group. Based on the experience retinoids are probably the second line drugs for the treatment of pediatric psoriasis which do not respond to topical therapies and phototherapy. Using acitretin in a low dose and with proper physical examinations and laboratory investigations will reduce the hazard of potential serious adverse events. This article gives the review of the use of acitretin in pediatric psoriasis.

Keywords: acitretin; pediatric; psoriasis; retinoid.

Publication types

  • Review

MeSH terms

  • Acitretin / adverse effects
  • Acitretin / therapeutic use*
  • Adolescent
  • Age of Onset
  • Child
  • Child, Preschool
  • Dermatologic Agents / adverse effects
  • Dermatologic Agents / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Psoriasis / diagnosis
  • Psoriasis / drug therapy*
  • Psoriasis / epidemiology
  • Skin / drug effects*
  • Skin / pathology
  • Treatment Outcome

Substances

  • Dermatologic Agents
  • Acitretin